GlassScriptPhysician profile
Sameh Elguizaoui
NPI 1568755460
$134,464.95
in general payments reported to CMS, 2019-2025
33 companies · $5,612 in 2025
The $5,612 reported for 2025 was more than what 82% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,048 · 2020: $3,201 · 2021: $7,802 · 2022: $9,353 · 2023: $93K · 2024: $13K · 2025: $5,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $90K · Food and Beverage: $7,707 · Consulting Fee: $6,888 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Travel and Lodging: $3,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $90,337.07 |
| Food and Beverage | $7,707.39 |
| Consulting Fee | $6,887.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Travel and Lodging | $3,378.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $91,448.37 | 2022-2025 | Tapestry |
| Globus Medical, INC. | $8,662.71 | 2021-2024 | Excelsiusgps Robotic Navigation System, Clavicular Fracture Fixation, Distal Radius II |
| Depuy Synthes Products, INC. | $8,100.00 | 2021-2022 | |
| Arthrex, INC. | $6,310.84 | 2023-2025 | |
| Stryker Corporation | $3,352.79 | 2019-2025 | Variax, Alphavent, Inspace |
| Surgalign Spine Technologies, INC. | $2,596.35 | 2019-2020 | |
| Geistlich Pharma, North America, INC. | $2,104.66 | 2022-2023 | Bio-Materials |
| Depuy Synthes Sales INC. | $2,033.33 | 2020-2024 | Rigidloop, Dynacord, Twistr |
| Gotham Surgical Solutions & Devices, INC. | $1,468.25 | 2021-2022 | |
| Polynovo North America LLC | $1,463.10 | 2023-2025 | Novosorb Btm |
| Suvon Surgical LLC | $786.41 | 2024-2025 | |
| Sanara Medtech INC. | $733.42 | 2024-2025 | Celleraterx, Celleraterx |
| Davol INC. | $566.84 | 2021-2023 | Arista Ah Flexitip |
| Embody, INC. | $489.69 | 2021-2022 | |
| Bioventus LLC | $453.75 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $415.19 | 2021 | |
| Arthrosurface Incorporated | $376.88 | 2019 | |
| Becton, Dickinson and Company | $338.28 | 2022 | |
| Joint Restoration Foundation, INC. | $289.48 | 2019 | |
| Kerecis Limited | $279.16 | 2022 | |
| Horizon Therapeutics Plc | $271.90 | 2019-2020 | |
| Rti Surgical, INC | $254.18 | 2020-2023 | |
| Djo, LLC | $225.68 | 2023-2025 | Cmf |
| Orthofix Medical, INC. | $222.37 | 2020-2025 | Physio-Stim |
| Miach Orthopaedics, INC. | $205.88 | 2024 | |
| Orthalign INC | $167.27 | 2025 | Orthalign Plus |
| Lima USA, INC. | $149.68 | 2019 | |
| Linvatec Corporation | $145.61 | 2022 | |
| Acumed LLC | $145.47 | 2020 | |
| Smith+Nephew, INC. | $142.30 | 2020 | |
| Avanos Medical | $117.27 | 2025 | Coolief Cooled Radiofrequency |
| Lifenet Health | $114.20 | 2023 | |
| Paragon 28, INC. | $33.64 | 2024 | Grappler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$308,328.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Elguizaoui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.